Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
Hematologic Oncology Update
00:00
CAR T mechanism, timing, and steroids' role
Dr Lunning explains CAR T timelines, CRS/ICANS biology, IL-6 blockade, and how steroids act as a 'brake' on CAR T activity.
Play episode from 04:41
Transcript
